GRIN2B and Alzheimer disease: Taken together, the results obtained in this study indicated that optimal antagonism of GluN2B-NMDAR allowed to restore synaptic functionality in AD through normalizing intrinsic excitability and molecular pathways, responsible for LTP induction.